Custom Antibody Discovery Services
Therapeutic/Diagnostic/Research Antibody Development
Key Facts
About RevMAB
RevMAB is a private, revenue-generating biotech company with a focus on recombinant monoclonal antibody discovery and development. Its core technology enables the generation of rabbit and goat monoclonal antibodies for challenging targets, including specific mutations, post-translational modifications, and small molecules, which are difficult to address with conventional methods. The company operates a hybrid business model, offering custom antibody discovery services while also commercializing a catalog of research-use-only antibodies and raw materials for diagnostic assays. Its primary market opportunities lie in providing critical reagents for oncology diagnostics, companion diagnostics, and early-stage therapeutic antibody discovery.
View full company profile